Philadelphia embraces a vision of recovery, resilience, and self-determination. We continue to shift to a model of care directed by the person in recovery. In this model, professional treatment is one aspect among many that supports people in managing their own conditions while building their own recovery resources. This recovery process should be viewed as a lifetime journey. Transformation to a recovery orientation in behavioral health is possible by focusing on the central role of individuals and families in responding to, managing, and overcoming these serious illnesses. This focus must be an organizing point for the entire system.

The mission of the Bucks County Drug and Alcohol Commission, Inc. (BCDAC, Inc.) is to reduce the use of tobacco and eliminate the use of illegal drugs and the abuse, misuse of and addiction to alcohol and other drugs. As the state and locally designated Single County Authority (SCA) for alcohol, tobacco and other drugs, our agency will work continuously to ensure the provision of a comprehensive and balanced continuum of quality prevention, intervention and treatment services for the county.

We are an independent, non-profit organization whose mission is to provide resources and opportunities to reduce the impact of addiction and to improve related health issues for the communities of Southeast Pennsylvania (Bucks, Chester, Delaware, Montgomery and Philadelphia counties). We accomplish this through prevention, consultation, education, advocacy, assessment, intervention and treatment services. We will make available our services to all, regardless of ability to pay, ethnicity, race, gender, age or sexual/gender orientation.

Seabrook House has been helping families find the courage to recover from alcoholism and drug addiction since 1974. The non-profit, internationally recognized New Jersey based facility assists patients in restoring their lives using the 12-Step principles of recovery. Seabrook House provides detoxification and inpatient rehabilitation for adults. Treatment ranges from 30, 60, 90, 120 days with facilities in New Jersey and Pennsylvania. To contact Seabrook House, please visit the organization’s web site at www.SeabrookHouse.org, or call the 24-hour help line at 1-800-761-7575.

Celebrate Eagleville Hospital's One Hundredth Anniversary. A Celebration Event on June 26, 2009 2pm-8pm and The Addiction-Trauma Connection October 2, 2009 9am-5pm RSVP 610.635.7406. Eagleville is a private, non-profit, multi-faceted service, prevention, research, education, and training organization. The hospital serves as a regional resource for the treatment and prevention of alcohol and drug abuse, as well as a national resource for training and research for addiction and related conditions.

Gaudenzia helps people affected by chemical dependency, mental illness and related conditions to achieve a better quality of life-allowing them to live as productive and accountable individuals. This is accomplished through comprehensive treatment and prevention methods guided by a philosophy of mutual concern and responsibility. Gaudenzia also conducts research and educates the community on the causes, treatment and prevention of addictions, mental illness and related conditions.

Reckitt Benckiser Pharmaceuticals Inc. is a specialty pharmaceutical company that distributes Suboxone® (buprenorphine and naloxone [2 mg/0.5 mg and 8 mg/2 mg] sublingual tablets) C-III and Subutex® (buprenorphine [2 mg and 8 mg] sublingual tablets) C-III, to treat opioid dependence in a medical office-based setting. Suboxone and Subutex, manufactured by Reckitt Benckiser Healthcare (UK) Ltd., are the only controlled medications under the Drug Addiction Treatment Act of 2000 approved by the FDA for office-based treatment of opioid dependence. Reckitt Benckiser Pharmaceuticals Inc. is committed to expanding access to medical therapies for patients suffering from the chronic, relapsing brain disease of opioid dependence. For more information, visit turntohelp.com, heretohelpprogram.com, or suboxone.com. Reckitt Benckiser Pharmaceuticals Inc. is a wholly-owned subsidiary of Reckitt Benckiser Group plc, a publicly traded UK firm. Suboxone® and Subutex® are registered trademarks of Reckitt Benckiser Healthcare (UK) Ltd.